ATE80740T1 - Immunassay-verfahren. - Google Patents

Immunassay-verfahren.

Info

Publication number
ATE80740T1
ATE80740T1 AT88904993T AT88904993T ATE80740T1 AT E80740 T1 ATE80740 T1 AT E80740T1 AT 88904993 T AT88904993 T AT 88904993T AT 88904993 T AT88904993 T AT 88904993T AT E80740 T1 ATE80740 T1 AT E80740T1
Authority
AT
Austria
Prior art keywords
antigen
labelled
immunassay
procedure
specimen
Prior art date
Application number
AT88904993T
Other languages
English (en)
Inventor
Michael Strachan Walker
Roger Henry Casburn-Budd
Original Assignee
Cambridge Life Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26292330&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE80740(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB878713418A external-priority patent/GB8713418D0/en
Priority claimed from GB878714213A external-priority patent/GB8714213D0/en
Application filed by Cambridge Life Sciences filed Critical Cambridge Life Sciences
Application granted granted Critical
Publication of ATE80740T1 publication Critical patent/ATE80740T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT88904993T 1987-06-09 1988-06-08 Immunassay-verfahren. ATE80740T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB878713418A GB8713418D0 (en) 1987-06-09 1987-06-09 Assay
GB878714213A GB8714213D0 (en) 1987-06-17 1987-06-17 Assay
PCT/GB1988/000446 WO1988009933A1 (en) 1987-06-09 1988-06-08 Immunoassay method
EP88904993A EP0366673B1 (de) 1987-06-09 1988-06-08 Immunassay-verfahren

Publications (1)

Publication Number Publication Date
ATE80740T1 true ATE80740T1 (de) 1992-10-15

Family

ID=26292330

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88904993T ATE80740T1 (de) 1987-06-09 1988-06-08 Immunassay-verfahren.

Country Status (5)

Country Link
EP (1) EP0366673B1 (de)
JP (1) JPH02503951A (de)
AT (1) ATE80740T1 (de)
DE (1) DE3874741T2 (de)
WO (1) WO1988009933A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164374A (en) * 1990-12-17 1992-11-17 Monsanto Company Use of oligosaccharides for treatment of arthritis
ATE331952T1 (de) * 1994-07-25 2006-07-15 Roche Diagnostics Gmbh Bestimmung von spezifischem immunglobulin unter verwendung multipler antigene
DE4430973A1 (de) * 1994-07-25 1996-02-01 Boehringer Mannheim Gmbh Hapten-markierte Peptide
EP0774120B1 (de) 1994-07-25 2009-08-26 Roche Diagnostics GmbH Metallchelat-markierte peptide
GB9719357D0 (en) * 1997-09-11 1997-11-12 Ortho Clinical Diagnostics Immunoassay Utilizing Two Incubations With Labelled Antigen
MXPA02010643A (es) 2000-04-26 2004-05-17 Land O Lakes Inc Un metodo de tratamiento de proteinas de soya y un producto de proteina de soya producido mediante este metodo.
GB0128583D0 (en) * 2001-11-28 2002-01-23 Rsr Ltd Detection of autoantibodies indicative of diabetes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4189466A (en) * 1975-09-19 1980-02-19 Technical Research Affiliates, Inc. Detection of rheumatoid factor by antibody sensitized microbial particles
US4067959A (en) * 1976-05-10 1978-01-10 International Diagnostic Technology, Inc. Indirect solid surface test for antigens or antibodies
GB2029011B (en) * 1978-09-01 1983-02-02 Coulson W Use of a synthetic bifunctional ligand for the immunimetric determination of the concentration ratio of two solutes
GB2158578B (en) * 1984-05-08 1988-03-09 Farmos Group Ltd Immunometric method for the determination of a hapten
CA1256369A (en) * 1985-02-26 1989-06-27 W. Carl Saxinger Detection of human t-cell leukemia virus type iii

Also Published As

Publication number Publication date
EP0366673A1 (de) 1990-05-09
DE3874741D1 (de) 1992-10-22
WO1988009933A1 (en) 1988-12-15
JPH02503951A (ja) 1990-11-15
DE3874741T2 (de) 1993-07-22
EP0366673B1 (de) 1992-09-16

Similar Documents

Publication Publication Date Title
DK212986A (da) Fremgangsmaade til bestemmelse af et stof i en praeve
SE8102558L (sv) Immunologisk bestemmningsmetod
SE7904386L (sv) Biologisk provmetod med utnyttjande av fast fas
FI90799C (fi) Immunologisia määritysmenetelmiä ja niissä käytettävä reagenssi
SE7907535L (sv) Diagnostiskt forfarande
DE3584035D1 (de) Nachweis von menschlichem cytomegalovirus-spezifischem igm.
ES511156A0 (es) Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo.
NO843591L (no) Fremgangsmaate for aa bestemme pivka-ii-innhold i blodplasma og middel for utfoerelse av denne
ATE80740T1 (de) Immunassay-verfahren.
DE69819643D1 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
FI874280A0 (fi) Immunometriskt bestaemningsfoerfarande.
JPS6428560A (en) Immunometric measurement
ES8601479A1 (es) Procedimiento para la deteminacion de un antigeno polivalente
EP0366092A3 (de) Verfahren zur Bestimmung von für ein Antigen klassenspezifischen Antikörpern und dazu geeignetes Reagenz
DE59109139D1 (de) Immunologischer Nachweis von Metolachlor
ATE50459T1 (de) Verfahren zur bestimmung einer immunologisch bindefaehigen substanz.
ES8308924A1 (es) "un procedimiento para la preparacion de un complejo inmunologicamente activo".
DE3273844D1 (en) Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor
ES8707798A1 (es) Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b
MY101223A (en) Determination of analyte concentration
ATE122150T1 (de) Einschritt-immuntest zur bestimmung von antigen- spezifischen antikörpern aller immunglobulin- klassen und dazu geeignetes mittel.
ES546338A0 (es) Procedimiento para la determinacion de una sustancia capaz de fijarse inmunologicamente
ATE173543T1 (de) Verfahren zum nachweis einer cmv-infektion
NO852058L (no) Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
ES2016992B3 (es) Reagente y procedimiento en la determinacion c 3a mediante ensayo inmunoquimico.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
RZN Patent revoked